Get the full Oesophageal Cancer public health report
The full report covers burden, affected groups, risk factors, screening, treatment coverage, programmes, gaps and outlook, with a source and year for every figure.
| Place | Active trials | Report |
|---|---|---|
| World | 894 | View report |
| Africa | 7 | View report |
 DR Congo | 0 | View report |
 Ethiopia | 0 | View report |
 Ghana | 0 | View report |
 Kenya | 1 | View report |
 Nigeria | 0 | View report |
 Tanzania | 2 | View report |
 Uganda | 0 | View report |
Public clinical research
894 active trials found worldwide on ClinicalTrials.gov.
See the public searchLatest public research
- Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma.European journal of pharmacology, 2026
- Discovery of Novel Quinazoline-Based KDM1A Inhibitors as Dual Inducers of Ferroptosis and Apoptosis in Esophageal Cancer.Journal of medicinal chemistry, 2026
- Palliative care utilization among adults hospitalized with metastatic gastrointestinal malignancies in the United States, 2016 to 2022: national trends, cancer-type variation, and predictors of consultation.Proceedings (Baylor University. Medical Center), 2026
- Editorial: Advances in esophageal cancer: treatment updates and future challenges.Frontiers in surgery, 2026
- Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan.Clinical case reports, 2026
Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.